Functional and structural consequences of epithelial cell invasion by Bordetella pertussis adenylate cyclase toxin.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2020
Historique:
received: 17 01 2020
accepted: 18 04 2020
entrez: 12 5 2020
pubmed: 12 5 2020
medline: 24 7 2020
Statut: epublish

Résumé

Bordetella pertussis, the causative agent of whopping cough, produces an adenylate cyclase toxin (CyaA) that plays a key role in the host colonization by targeting innate immune cells which express CD11b/CD18, the cellular receptor of CyaA. CyaA is also able to invade non-phagocytic cells, via a unique entry pathway consisting in a direct translocation of its catalytic domain across the cytoplasmic membrane of the cells. Within the cells, CyaA is activated by calmodulin to produce high levels of cyclic adenosine monophosphate (cAMP) and alter cellular physiology. In this study, we explored the effects of CyaA toxin on the cellular and molecular structure remodeling of A549 alveolar epithelial cells. Using classical imaging techniques, biochemical and functional tests, as well as advanced cell mechanics method, we quantify the structural and functional consequences of the massive increase of intracellular cyclic AMP induced by the toxin: cell shape rounding associated to adhesion weakening process, actin structure remodeling for the cortical and dense components, increase in cytoskeleton stiffness, and inhibition of migration and repair. We also show that, at low concentrations (0.5 nM), CyaA could significantly impair the migration and wound healing capacities of the intoxicated alveolar epithelial cells. As such concentrations might be reached locally during B. pertussis infection, our results suggest that the CyaA, beyond its major role in disabling innate immune cells, might also contribute to the local alteration of the epithelial barrier of the respiratory tract, a hallmark of pertussis.

Identifiants

pubmed: 32392246
doi: 10.1371/journal.pone.0228606
pii: PONE-D-20-01560
pmc: PMC7213728
doi:

Substances chimiques

Adenylate Cyclase Toxin 0
Calmodulin 0
Cyclic AMP E0399OZS9N

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0228606

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Biol Cell. 2017 Aug;109(8):293-311
pubmed: 28597954
Infect Immun. 2010 Mar;78(3):907-13
pubmed: 20065021
Cell Physiol Biochem. 2010;25(1):71-80
pubmed: 20054146
Toxins (Basel). 2017 Sep 21;9(10):
pubmed: 28934133
J Biol Chem. 2010 Apr 2;285(14):10662-70
pubmed: 20139088
J Cell Sci. 2011 Apr 15;124(Pt 8):1195-205
pubmed: 21444750
Infect Immun. 2018 Feb 20;86(3):
pubmed: 29203545
Cancer Cell. 2005 Sep;8(3):241-54
pubmed: 16169468
Future Microbiol. 2010 Mar;5(3):455-69
pubmed: 20210554
Biochim Biophys Acta. 2004 Jul 5;1692(2-3):159-74
pubmed: 15246685
J Cell Sci. 1999 Jan;112 ( Pt 2):243-52
pubmed: 9858477
Sci Rep. 2017 Feb 10;7:42065
pubmed: 28186111
Toxins (Basel). 2018 Jul 20;10(7):
pubmed: 30037010
J Biol Chem. 1992 Nov 5;267(31):22599-605
pubmed: 1429610
J Biol Chem. 1992 Feb 5;267(4):2244-50
pubmed: 1733931
J Cell Sci. 2009 Apr 15;122(Pt 8):1059-69
pubmed: 19339545
Nat Struct Biol. 2003 Dec;10(12):995-1001
pubmed: 14608374
Science. 1997 May 30;276(5317):1425-8
pubmed: 9162012
J Cell Sci. 2007 Feb 1;120(Pt 3):456-67
pubmed: 17227794
FEMS Microbiol Lett. 2008 Feb;279(2):174-9
pubmed: 18179583
Sci Rep. 2015 Sep 08;5:13774
pubmed: 26346097
J Cell Biol. 2001 Jun 11;153(6):1175-86
pubmed: 11402062
J Biol Chem. 2014 Oct 31;289(44):30702-16
pubmed: 25231985
Cancer Lett. 2013 Oct 1;339(1):33-41
pubmed: 23911936
Annu Rev Cell Dev Biol. 2013;29:27-61
pubmed: 24099083
Science. 1993 May 21;260(5111):1124-7
pubmed: 7684161
EMBO J. 2006 Nov 15;25(22):5405-13
pubmed: 17082768
Infect Immun. 2013 May;81(5):1390-8
pubmed: 23429530
Ann Biomed Eng. 2003 Nov;31(10):1263-78
pubmed: 14649500
Exp Cell Res. 1998 Sep 15;243(2):359-66
pubmed: 9743595
Small GTPases. 2014;5:e27958
pubmed: 24607953
J Immunol. 2008 Oct 15;181(8):5587-97
pubmed: 18832717
Toxins (Basel). 2019 Jun 20;11(6):
pubmed: 31226835
J Biol Chem. 2002 May 31;277(22):19800-5
pubmed: 11893752
Methods Cell Biol. 2007;83:443-72
pubmed: 17613320
Cells. 2016 Apr 06;5(2):
pubmed: 27058559
Curr Opin Microbiol. 2006 Feb;9(1):69-75
pubmed: 16406775
Pharmacol Ther. 2014 Sep;143(3):295-304
pubmed: 24704321
J Cell Physiol. 2005 Aug;204(2):412-22
pubmed: 15706595
Infect Immun. 1993 Oct;61(10):4064-71
pubmed: 8406793
J Biol Chem. 1991 Feb 15;266(5):3154-61
pubmed: 1847141
Cell Signal. 2013 May;25(5):1064-74
pubmed: 23416464
Respir Physiol Neurobiol. 2008 Nov 30;163(1-3):3-16
pubmed: 18565804
J R Soc Interface. 2011 Mar 6;8(56):305-11
pubmed: 20826475
Trends Microbiol. 1999 Apr;7(4):172-6
pubmed: 10217833
FASEB J. 2019 Sep;33(9):10065-10076
pubmed: 31226003
Cytometry B Clin Cytom. 2004 Jul;60(1):31-6
pubmed: 15221867
Mol Biol Cell. 2001 Sep;12(9):2711-20
pubmed: 11553710
Int J Oncol. 2009 Jun;34(6):1717-26
pubmed: 19424590
Oncotarget. 2017 Jul 22;8(41):69945-69960
pubmed: 29050254
FEMS Microbiol Lett. 1995 Dec 1;134(1):27-32
pubmed: 8593951
Infect Immun. 1992 Nov;60(11):4578-85
pubmed: 1398970
Int J Biochem Cell Biol. 2002 Jul;34(7):746-61
pubmed: 11950592
Cell Host Microbe. 2011 Nov 17;10(5):464-74
pubmed: 22100162
J Biol Chem. 2017 Aug 25;292(34):14080-14091
pubmed: 28655771
Trends Cell Biol. 2002 Jun;12(6):258-66
pubmed: 12074885
Toxins (Basel). 2017 Sep 11;9(9):
pubmed: 28892012
Am J Physiol Cell Physiol. 2002 Mar;282(3):C606-16
pubmed: 11832346
J Exp Med. 2001 May 7;193(9):1035-44
pubmed: 11342588
Innate Immun. 2010 Feb;16(1):14-26
pubmed: 19710103
J Biol Chem. 1985 May 10;260(9):5526-32
pubmed: 2859287
Nat Rev Microbiol. 2014 Apr;12(4):274-88
pubmed: 24608338
Trends Cell Biol. 2011 Dec;21(12):718-26
pubmed: 21924908
J Exp Med. 2011 Jun 6;208(6):1317-30
pubmed: 21576384
J Biol Chem. 2008 May 16;283(20):13799-805
pubmed: 18353776
J Biol Chem. 2010 Jan 1;285(1):357-64
pubmed: 19875442
Front Immunol. 2018 May 01;9:919
pubmed: 29765373
Pathog Dis. 2015 Dec;73(9):ftv081
pubmed: 26432818
Biomech Model Mechanobiol. 2016 Aug;15(4):947-63
pubmed: 26459324
Cancer Res. 1988 Nov 15;48(22):6550-4
pubmed: 2460224
J Immunol. 2017 Feb 1;198(3):1285-1296
pubmed: 28039302

Auteurs

Christelle Angely (C)

Equipe 13, Biomécanique & Appareil Respiratoire, Inserm U955, Créteil, France.
UMR 955, UPEC, Université Paris-Est, Créteil, France.
ERL 7000, CNRS, Créteil, France.

Daniel Ladant (D)

Unité de Biochimie des Interactions Macromoléculaires (CNRS UMR 3528), Département de Biologie Structurale et Chimie, Institut Pasteur, Paris, France.

Emmanuelle Planus (E)

Institut pour l'Avancée des Biosciences (IAB), Centre de Recherche UGA/ Inserm U1209 / CNRS UMR 5309, La Tronche, France.

Bruno Louis (B)

Equipe 13, Biomécanique & Appareil Respiratoire, Inserm U955, Créteil, France.
UMR 955, UPEC, Université Paris-Est, Créteil, France.
ERL 7000, CNRS, Créteil, France.

Marcel Filoche (M)

Equipe 13, Biomécanique & Appareil Respiratoire, Inserm U955, Créteil, France.
UMR 955, UPEC, Université Paris-Est, Créteil, France.
ERL 7000, CNRS, Créteil, France.
Laboratoire de Physique de la Matière Condensée, Ecole Polytechnique, CNRS, IP Paris, Palaiseau, France.

Alexandre Chenal (A)

Unité de Biochimie des Interactions Macromoléculaires (CNRS UMR 3528), Département de Biologie Structurale et Chimie, Institut Pasteur, Paris, France.

Daniel Isabey (D)

Equipe 13, Biomécanique & Appareil Respiratoire, Inserm U955, Créteil, France.
UMR 955, UPEC, Université Paris-Est, Créteil, France.
ERL 7000, CNRS, Créteil, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH